1
|
Rock J, Garcia D, Espino O, Shetu SA, Chan-Bacab MJ, Moo-Puc R, Patel NB, Rivera G, Bandyopadhyay D. Benzopyrazine-Based Small Molecule Inhibitors As Trypanocidal and Leishmanicidal Agents: Green Synthesis, In Vitro, and In Silico Evaluations. Front Chem 2021; 9:725892. [PMID: 34604170 PMCID: PMC8484882 DOI: 10.3389/fchem.2021.725892] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Accepted: 09/01/2021] [Indexed: 01/18/2023] Open
Abstract
World Health Organization (WHO) identified twenty tropical disease categories as neglected tropical diseases (NTDs). Chagas' disease (also known as American trypanosomiasis) and leishmaniasis are two major classes of NTDs. The total number of mortality, morbidity, and disability attributed each year due to these two categories of diseases in magnitudes is much higher than the so-called elite diseases like cancer, diabetes, AIDS, cardiovascular and neurodegenerative diseases. Impoverished communities around the world are the major victim of NTDs. The development of new and novel drugs in the battle against Chagas' disease and leishmaniasis is highly anticipated. An easy and straightforward on-water green access to synthesize benzopyrazines is reported. This ultrasound-assisted procedure does not require any catalyst/support/additive/hazardous solvents and maintains a high atom economy. A series of eleven benzopyrazines has been synthesized, and most of the synthesized compounds possess the drug-likeness following Lipinski's "Rule of 5". Benzopyrazines 3 and 4 demonstrated moderate leishmanicidal activity against L. mexicana (M378) strain. The selective lead compound 1 showed good leishmanicidal, and trypanocidal activities (in vitro) against both L. mexicana (M378) and T. cruzi (NINOA) strains compared to the standard controls. The in vitro trypanocidal and leishmanicidal activities of the lead compound 1 have been validated by molecular docking studies against four biomolecular drug targets viz. T. cruzi histidyl-tRNA synthetase, T. cruzi trans-sialidase, leishmanial rRNA A-site, and leishmania major N-myristoyl transferase.
Collapse
Affiliation(s)
- Jonathan Rock
- Department of Chemistry, University of Texas Rio Grande Valley, Edinburg, TX, United States
| | - Daniel Garcia
- Department of Chemistry, University of Texas Rio Grande Valley, Edinburg, TX, United States
| | - Omar Espino
- Department of Chemistry, University of Texas Rio Grande Valley, Edinburg, TX, United States
| | - Shaila A. Shetu
- Department of Chemistry, University of Texas Rio Grande Valley, Edinburg, TX, United States
| | - Manuel J. Chan-Bacab
- Departamento de Microbiología Ambiental y Biotecnología, Universidad Autónoma de Campeche, Campeche, México
| | - Rosa Moo-Puc
- Unidad Médica de Alta Especialidad, Instituto Mexicano Del Seguro Social, Mérida, México
| | - Navin B. Patel
- Department of Chemistry, Veer Narmad South Gujarat University, Gujrat, India
| | - Gildardo Rivera
- Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, México
| | - Debasish Bandyopadhyay
- Department of Chemistry, University of Texas Rio Grande Valley, Edinburg, TX, United States
- School of Earth Environment and Marine Sciences (SEEMS), University of Texas Rio Grande Valley, Edinburg, TX, United States
| |
Collapse
|
2
|
Zheng CB, Gao WC, Pang PP, Ma X, Peng LC, Yang L, Li X. Synthesis and vasorelaxant evaluation of novel 7-methoxyl-2,3-disubstituted-quinoxaline derivatives. Bioorg Med Chem Lett 2021; 36:127785. [PMID: 33444740 DOI: 10.1016/j.bmcl.2021.127785] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 12/11/2020] [Accepted: 01/05/2021] [Indexed: 01/02/2023]
Abstract
An array of novel 7-methoxyl-2,3-disubstituted quinoxaline derivatives was designed, synthesized and their potential antihypertensive activities were examined, in an attempt to discover potent small molecules with vasorelaxant effects. The vasoactivities of these compounds on vascular tone, as well as underlying mechanisms were hereby explored. Results showed that five compounds (7s, 7t, 7v, 7w, 7γ) could induce endothelium-independent relaxation in high extracellular K+- and phenylephrine-precontracted C57 mice aortic rings. These five compounds, unlike other commonly used vasodilators, could slowly but effectively inhibit vasoconstriction.
Collapse
Affiliation(s)
- Chang-Bo Zheng
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China
| | - Wen-Cong Gao
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China
| | - Pan-Pan Pang
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China
| | - Xin Ma
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China
| | - Li-Chun Peng
- School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China
| | - Liang Yang
- Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Science, Shandong University, Ji'nan, Shandong 250012, China
| | - Xun Li
- Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong 250002, China.
| |
Collapse
|
3
|
Capasso A, Bagby SM, Dailey KL, Currimjee N, Yacob BW, Ionkina A, Frank JG, Kim DJ, George C, Lee YB, Benaim E, Gittleman B, Hartman SJ, Tan AC, Kim J, Pitts TM, Eckhardt SG, Tentler JJ, Diamond JR. First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast Cancer. Mol Cancer Ther 2019; 18:1916-1925. [PMID: 31488700 DOI: 10.1158/1535-7163.mct-18-1334] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2018] [Revised: 06/27/2019] [Accepted: 08/23/2019] [Indexed: 12/31/2022]
Abstract
RX-5902 is a first-in-class anticancer agent targeting phosphorylated-p68 and attenuating nuclear shuttling of β-catenin. The purpose of this study was to evaluate the efficacy of RX-5902 in preclinical models of triple-negative breast cancer (TNBC) and to explore effects on β-catenin expression. A panel of 18 TNBC cell lines was exposed to RX-5902, and changes in proliferation, apoptosis, cellular ploidy, and effector protein expression were assessed. Gene expression profiling was used in sensitive and resistant cell lines with pathway analysis to explore pathways associated with sensitivity to RX-5902. The activity of RX-5902 was confirmed in vivo in cell line and patient-derived tumor xenograft (PDX) models. RX-5902 demonstrated potent antiproliferative activity in vitro against TNBC cell lines with an average IC50 of 56 nmol/L in sensitive cell lines. RX-5902 treatment resulted in the induction of apoptosis, G2-M cell-cycle arrest, and aneuploidy in a subset of cell lines. RX-5902 was active in vivo against TNBC PDX models, and treatment resulted in a decrease in nuclear β-catenin. RX-5902 exhibited dose-proportional pharmacokinetics and plasma and tumor tissue in nude mice. Pathway analysis demonstrated an increase in the epithelial-to-mesenchymal transformation (EMT), TGFβ, and Wnt/β-catenin pathways associated with sensitivity to RX-5902. RX-5902 is active against in vitro and in vivo preclinical models of TNBC. Target engagement was confirmed with decreases in nuclear β-catenin and MCL-1 observed, confirming the proposed mechanism of action. This study supports the continued investigation of RX-5902 in TNBC and combinations with immunotherapy.
Collapse
Affiliation(s)
- Anna Capasso
- Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, University of Texas at Austin, Austin, Texas.
| | - Stacey M Bagby
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Kyrie L Dailey
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Naomi Currimjee
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Betelehem W Yacob
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Anastasia Ionkina
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | | | | | | | - Young B Lee
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland
| | - Ely Benaim
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland
| | - Brian Gittleman
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Sarah J Hartman
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Aik Choon Tan
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Jihye Kim
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Todd M Pitts
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - S Gail Eckhardt
- Department of Oncology, Dell Medical School, Livestrong Cancer Institutes, University of Texas at Austin, Austin, Texas
| | - John J Tentler
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Jennifer R Diamond
- University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| |
Collapse
|
4
|
3‐(α‐Chlorobenzyl)quinoxalin‐2(1
H
)‐ones as Versatile Reagents for the Synthesis of 3‐Benzylquinoxalin‐2(1
H
)‐ones and Thiazolo[3,4‐
a
]quinoxalin‐4(5
H
)‐ones. J Heterocycl Chem 2019. [DOI: 10.1002/jhet.3616] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
5
|
St Hilaire VR, Hopkins WE, Miller YS, Dandepally SR, Williams AL. Regioselective addition of Grignard reagents to N-acylpyrazinium salts: synthesis of substituted 1,2-dihydropyrazines and Δ 5-2-oxopiperazines. Beilstein J Org Chem 2019; 15:72-78. [PMID: 30680041 PMCID: PMC6334805 DOI: 10.3762/bjoc.15.8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2018] [Accepted: 12/10/2018] [Indexed: 11/23/2022] Open
Abstract
The regioselective addition of Grignard reagents to mono- and disubstituted N-acylpyrazinium salts affording substituted 1,2-dihydropyrazines in modest to excellent yields (45–100%) is described. Under acidic conditions, these 1,2-dihydropyrazines can be converted to substituted Δ5-2-oxopiperazines providing a simple and efficient approach towards their preparation.
Collapse
Affiliation(s)
- Valentine R St Hilaire
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
| | - William E Hopkins
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
| | - Yenteeo S Miller
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
| | - Srinivasa R Dandepally
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States
| | - Alfred L Williams
- Biomanufacturing Research Institute and Technology Enterprise (BRITE), North Carolina Central University, Durham, North Carolina 27707, United States.,Department of Pharmaceutical Sciences, North Carolina Central University, Durham, North Carolina 27707, United States
| |
Collapse
|
6
|
Babu LT, Jadhav GR, Paira P. Luminescent bis(benzo[ d]thiazolyl)quinoxaline: facile synthesis, nucleic acid and protein BSA interaction, live-cell imaging, biopharmaceutical research and cancer theranostic application. RSC Adv 2019; 9:8748-8752. [PMID: 35517674 PMCID: PMC9061853 DOI: 10.1039/c9ra01498e] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 02/28/2019] [Indexed: 12/31/2022] Open
Abstract
A series of quinoxaline-2-hydroxyphenylbenzothiazole scaffolds were synthesized and characterized using NMR, UV, fluorescence spectroscopy and LCMS. These newly synthesized compounds were found to be cytotoxic in human epithelioid cervix carcinoma (HeLa) and human colon cancer cell lines (Caco-2). Selectivity of the compounds 7e and 7g are more than 9 fold higher in Caco-2 cells with respect to the normal cell line HEK-293. The most fluorescent compound 7e has displayed high cytoselectivity, significant cellular uptake in HeLa cells and strong binding efficacy with DNA and BSA. The most potent compound 7g has primarily classified as BCS class 4 and BDDCS class 4. A series of luminescent bis(benzo[d]thiazolyl)quinoxalines have been synthesized and their fluorescence properties, anticancer potency, DNA and BSA interactions, cellular uptake, and metabolic stabilities are investigated.![]()
Collapse
Affiliation(s)
- Lavanya Thilak Babu
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore-632014
- India
| | - Gajanan Raosaheb Jadhav
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore-632014
- India
| | - Priyankar Paira
- Department of Chemistry
- School of Advanced Sciences
- Vellore Institute of Technology
- Vellore-632014
- India
| |
Collapse
|
7
|
Kaushal T, Srivastava G, Sharma A, Singh Negi A. An insight into medicinal chemistry of anticancer quinoxalines. Bioorg Med Chem 2018; 27:16-35. [PMID: 30502116 DOI: 10.1016/j.bmc.2018.11.021] [Citation(s) in RCA: 68] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2018] [Revised: 11/06/2018] [Accepted: 11/13/2018] [Indexed: 02/07/2023]
Abstract
Quinoxalines are benzopyrazines containing benzene and pyrazine rings fused together. In the recent past, quinoxalines have attracted Medicinal Chemists considerably for their syntheses and chemistry due to their distinct pharmacological activities. Diverse synthetic protocols have been developed via multicomponent reactions, single pot synthesis and combinatorial approach using efficient catalysts, reagents, and nano-composites etc. Further, the versatility of the quinoxaline core and its reasonable chemical simplicity devise it extremely promising source of bioactive compounds. Therefore, a wide variety of bioactive quinoxalines has been realised as antitumour, antifungal, anti-inflammatory, antimicrobial, and antiviral agents. Already, a few of them are clinical drugs while many more are under various phases of clinical trials. Present review focuses on chemistry and pharmacology (both efficacy and safety) of quinoxalines and also provides some insight in to their structure-activity relationship.
Collapse
Affiliation(s)
- Tanu Kaushal
- CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow 226 015, UP, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi 110001, India
| | - Gaurava Srivastava
- CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow 226 015, UP, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi 110001, India
| | - Ashok Sharma
- CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow 226 015, UP, India
| | - Arvind Singh Negi
- CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow 226 015, UP, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi 110001, India.
| |
Collapse
|
8
|
Kost GC, Yang MY, Li L, Zhang Y, Liu CY, Kim DJ, Ahn CH, Lee YB, Liu ZR. A Novel Anti-Cancer Agent, 1-(3,5-Dimethoxyphenyl)-4-[(6-Fluoro-2-Methoxyquinoxalin-3-yl)Aminocarbonyl] Piperazine (RX-5902), Interferes With β-Catenin Function Through Y593 Phospho-p68 RNA Helicase. J Cell Biochem 2016; 116:1595-601. [PMID: 25649741 DOI: 10.1002/jcb.25113] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2014] [Accepted: 01/23/2015] [Indexed: 02/04/2023]
Abstract
1-(3,5-Dimethoxyphenyl)-4-[(6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl] piperazine (RX-5902) exhibits strong growth inhibition in various human cancer cell lines with IC50 values ranging between 10 and 20 nM. In this study, we demonstrate that p68 RNA helicase is a cellular target of RX-5902 by the drug affinity responsive target stability (DARTS) method, and confirmed the direct binding of (3) H-labeled RX-5902 to Y593 phospho-p68 RNA helicase. We further demonstrated RX-5902 inhibited the β-catenin dependent ATPase activity of p68 RNA helicase in an in vitro system. Furthermore, we showed that treatment of cancer cells with RX-5902 resulted in the downregulation of the expression of certain genes, which are known to be regulated by the β-catenin pathway, such as c-Myc, cyclin D1 and p-c-Jun. Therefore, our study indicates that the inhibition of Y593 phospho-p68 helicase - β-catenin interaction by direct binding of RX-5902 to Y593 phospho-p68 RNA helicase may contribute to the anti-cancer activity of this compound.
Collapse
Affiliation(s)
- Gina Chun Kost
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland, 20850
| | - Mi Young Yang
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland, 20850
| | - Liangwei Li
- Department of Biology, Georgia State University, Atlanta, Georgia, 30303
| | - Yinwei Zhang
- Department of Biology, Georgia State University, Atlanta, Georgia, 30303
| | - Chia-Yi Liu
- Department of Biology, Georgia State University, Atlanta, Georgia, 30303
| | - Deog Joong Kim
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland, 20850
| | - Chang-Ho Ahn
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland, 20850
| | - Young Bok Lee
- Rexahn Pharmaceuticals, Inc., Rockville, Maryland, 20850
| | - Zhi-Ren Liu
- Department of Biology, Georgia State University, Atlanta, Georgia, 30303
| |
Collapse
|
9
|
Issa DAE, Habib NS, Abdel Wahab AE. Design, synthesis and biological evaluation of novel 1,2,4-triazolo and 1,2,4-triazino[4,3-a]quinoxalines as potential anticancer and antimicrobial agents. MEDCHEMCOMM 2015. [DOI: 10.1039/c4md00257a] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Compound 9a showed dual anticancer and antimicrobial activity and compound 16 showed a broad spectrum antimicrobial activity.
Collapse
Affiliation(s)
- Doaa A. E. Issa
- Department of Pharmaceutical Chemistry
- Faculty of Pharmacy
- University of Alexandria
- Alexandria
- Egypt
| | - Nargues S. Habib
- Department of Pharmaceutical Chemistry
- Faculty of Pharmacy
- University of Alexandria
- Alexandria
- Egypt
| | - Abeer E. Abdel Wahab
- Genetic Engineering and Biotechnology Research Institute (GEBRI)
- City for Scientific Research and Technology Application
- Alexandria
- Egypt
| |
Collapse
|
10
|
Present status of quinoxaline motifs: Excellent pathfinders in therapeutic medicine. Eur J Med Chem 2014; 85:688-715. [DOI: 10.1016/j.ejmech.2014.08.034] [Citation(s) in RCA: 79] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2013] [Revised: 08/07/2014] [Accepted: 08/08/2014] [Indexed: 11/18/2022]
|
11
|
Maichrowski J, Bhasin A, Sasse F, Kaufmann DE. Carbene-Catalyzed Aroylation of a 2-ChloroquinoxalineN-Oxide with Aromatic Aldehydes at Room Temperature. European J Org Chem 2014. [DOI: 10.1002/ejoc.201402252] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
12
|
SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT7 receptor ligands among phenylpiperazine hydantoin derivatives. Eur J Med Chem 2014; 78:324-39. [DOI: 10.1016/j.ejmech.2014.01.065] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2013] [Revised: 01/05/2014] [Accepted: 01/07/2014] [Indexed: 11/22/2022]
|
13
|
Lee D, Seo YH, Bae JS, Lee S, Lee TI, Gong YD, Lee T. An Efficient and Regioselective Synthesis of 2,3-Disubstituted 6-Aminoquinoxaline Derivatives Using Alkoxylation and Microwave-assisted Sonogashira Coupling. B KOREAN CHEM SOC 2013. [DOI: 10.5012/bkcs.2013.34.8.2522] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
14
|
Maichrowski J, Gjikaj M, Hübner EG, Bergmann B, Müller IB, Kaufmann DE. Efficient Synthesis of Quinoxaline Derivatives by Selective Modification of 3-Chloro-6-fluoroquinoxalin-2(1H)-one 4-Oxide. European J Org Chem 2013. [DOI: 10.1002/ejoc.201201569] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
|